ABCC1 , ABCG2 and FOXP3 : Predictive Biomarkers of Toxicity from Methotrexate Treatment in Patients Diagnosed with Moderate-to-Severe Psoriasis.
Cristina Membrive-JiménezSayleth Vieira-MarounNoelia Márquez-PeteYasmin CuraCristina Pérez-RamírezJesús Tercedor-SánchezAlberto Jiménez-MoralesMaría Del Carmen Ramírez TortosaPublished in: Biomedicines (2023)
polymorphisms can be considered to be risk biomarkers of toxicities in PS patients treated with MTX.